Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
By
Dr S Nasir Shah
PSORIASIS - epidemiology
Northern Europe
Denmark
Faroe Isles
USA
China
2%
2.9%
2.8%
1.4%
0.4%
PSORIASIS - genetics
HLA
Cw6
DR7
Linkage studies
Chromosome 17q
Chromosome 4q
PSORIASIS - genetics
Family studies
Twin studies
monozygotic twins 65-70% concordance
dizygotic twins
15-20% concordance
PSORIASIS - epidemiology
Type 1
Type 2
PSORIASIS - epidemiology
Type 1
Early onset
Familial segregation
HLA Cw6
PSORIASIS - epidemiology
Type 2
Late onset
No familial segregation
HLA Cw2
PSORIASIS - triggers
bacterial infection
skin injury koebner phenomenon
stress
drugs
antimalarials
lithium
beta-blockers
systemic steroids
Histology of Skin
Histopathology of Psoriasis
Clinical features - 1
Clinical features - 2
Types of Ps - Flexural
Types of Ps Palmo-plantar
Differential Diagnosis
Types of Ps - Genital Ps
Types of ps - Genital
Types of Ps - pustular Ps
Types of Ps
Extensive Chronic
Plaque Ps
/Suberythroderma
Types of Ps
Erythrodermic Ps
Psoriatic arthritis 1
Arthritis Mutilans 2
PSORIASIS treatment
Mild to moderate psoriasis 10%
PSORIASIS - treatment
Dithranol
Stable chronic plaque
Start with low concentration and test an area
before increasing the concentration
Avoid normal skin
Avoid face and flexures
Dithranol treatment
Dithranol treatment
Dithranol treatment
Relapse after
injudicious treatment
PSORIASIS - treatment
Scalp psoriasis
PSORIASIS treatment
Flexural Psoriasis
Moderately potent topical steroids
Combinations probably work better
PSORIASIS - treatment
Palmoplantar psoriasis
PSORIASIS - treatment
Psoriasis of the nail
Topical steroids
Methotrexate
Biologicals - etanercept
PSORIASIS - treatment
Palmoplantar pustular psoriasis
PSORIASIS treatment
Moderate to severe psoriasis
Phototherapy
Traditional systemic treatments
Biologicals
Hospital Admission
PSORIASIS - treatment
Phototherapy
UVB
Narrowband UVB
PUVA (psoralen + UVA)
Systemic treatments
Methotrexate
Acitretin
Ciclosprin
Biologicals
Fumerate
PSORIASIS - treatment
Hospital Admission
Dithranol in Lassars paste 0.1 2.0%
Crude Coal tar 1 30%
PSORIASIS - treatment
Systemic treatment absolute indications
Erythrodermic psoriasis
Pustular psoriasis
PSORIASIS - treatment
Systemic treatment relative indications
Extensive flexural psoriasis
Extensive chronic plaque psoriasis
elderly incapacitated
multiple frequent hospital admission
failure to respond to UVL
patient unable to have UVL
Dx?
D iagnosis
Dx?
End